• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肾细胞癌的异时转移潜能:依赖于肿瘤大小。

Metachronous metastatic potential of small renal cell carcinoma: dependence on tumor size.

机构信息

Department of Urology, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Urology. 2009 Dec;74(6):1271-5. doi: 10.1016/j.urology.2009.04.072. Epub 2009 Jul 17.

DOI:10.1016/j.urology.2009.04.072
PMID:19616288
Abstract

OBJECTIVES

To evaluate the association between tumor diameter and clinicopathologic characteristics and metastatic potential in small (< or = 4 cm) renal cell carcinoma (RCC).

METHODS

A total of 350 patients with an age range of 24-84 years (median, 54) were included in the study. Patients were categorized according to tumor diameter into 3 groups: < or = 2, 2.1-3.0, and 3.1-4.0 cm.

RESULTS

There were no significant differences in age, sex, histologic type, pathologic stage, and Fuhrman's grade according to tumor diameter. Tumor size did not predict synchronous metastatic disease. Distant metastases at diagnosis were documented in 2.1%, 1.6%, and 0.0% in patients with RCC of diameter < or = 2, 2.1-3, and 3.1-4 cm, respectively. During follow-up, recurrence or metastasis developed in 11 patients (3.5%) with a median time to metastasis of 43 months (range 7-104) in 345 patients with localized (N0M0) RCC. Metastases were diagnosed in 2 patients (0.9%) with RCC < or = 3 cm and in 9 patients (7.0%) with RCC 3.1-4.0 cm. Significant difference was noted in metastasis-free survival among groups (P = .023). Multivariate Cox proportional hazards model analysis showed that only tumor diameter was an independent predictor of metastasis-free survival (Hazard ratio, 5.344; 95% confidence interval, 1.137-25.127; P = .034).

CONCLUSIONS

Our findings suggest that risk of metachronous metastasis, but not synchronous metastasis, increases in RCC of diameter > 3.0 cm.

摘要

目的

评估肿瘤直径与小(≤4cm)肾细胞癌(RCC)的临床病理特征和转移潜能之间的关系。

方法

共纳入 350 例年龄 24-84 岁(中位年龄 54 岁)的患者。根据肿瘤直径将患者分为 3 组:≤2cm、2.1-3.0cm 和 3.1-4.0cm。

结果

肿瘤直径与年龄、性别、组织学类型、病理分期和 Fuhrman 分级无关。肿瘤大小并不能预测同步转移疾病。在诊断时,直径≤2cm、2.1-3cm 和 3.1-4cm 的 RCC 患者中,分别有 2.1%、1.6%和 0.0%发生远处转移。在 345 例局部(N0M0)RCC 患者中,中位随访时间为 43 个月(范围 7-104),11 例(3.5%)患者复发或转移。在直径≤3cm 的 RCC 患者中,2 例(0.9%)和直径 3.1-4.0cm 的 RCC 患者中 9 例(7.0%)诊断出转移。组间无病生存率存在显著差异(P=0.023)。多因素 Cox 比例风险模型分析显示,只有肿瘤直径是无病生存率的独立预测因子(危险比,5.344;95%置信区间,1.137-25.127;P=0.034)。

结论

我们的研究结果表明,直径>3.0cm 的 RCC 发生异时转移的风险增加,但同步转移的风险并未增加。

相似文献

1
Metachronous metastatic potential of small renal cell carcinoma: dependence on tumor size.小肾细胞癌的异时转移潜能:依赖于肿瘤大小。
Urology. 2009 Dec;74(6):1271-5. doi: 10.1016/j.urology.2009.04.072. Epub 2009 Jul 17.
2
External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.一项预测韩国pT2N0M0肾细胞癌患者生存率的国际多中心研究的外部验证
Urology. 2009 Aug;74(2):359-63. doi: 10.1016/j.urology.2009.02.037. Epub 2009 Jun 7.
3
Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma.在韩国肾嫌色细胞癌患者中核分级和肿瘤大小的意义:与传统肾细胞癌的比较。
Urol Oncol. 2011 Sep-Oct;29(5):487-91. doi: 10.1016/j.urolonc.2009.05.011. Epub 2009 Sep 19.
4
Metastatic potential of a renal mass according to original tumour size at presentation.根据初诊时原发肿瘤的大小判断肾肿瘤的转移潜能。
BJU Int. 2012 Jan;109(2):190-4; discussion 194. doi: 10.1111/j.1464-410X.2011.10184.x. Epub 2011 May 9.
5
Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.丝状肌动蛋白在肾透明细胞癌中的生物学意义:利用组织芯片技术对原发性和转移性肿瘤组织进行系统分析
Urology. 2006 Sep;68(3):518-22. doi: 10.1016/j.urology.2006.03.032. Epub 2006 Sep 18.
6
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.现代非转移性肾细胞癌中临床病理及脱氧核糖核酸流式细胞术变量的预后意义
Urol Oncol. 2005 Sep-Oct;23(5):328-32. doi: 10.1016/j.urolonc.2005.01.017.
7
Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.肾细胞癌患者原发性肿瘤坏死的临床病理与分子相关性
Cancer. 2005 Jun 15;103(12):2517-25. doi: 10.1002/cncr.21127.
8
Proposal for revision of the TNM classification system for renal cell carcinoma.肾细胞癌TNM分类系统修订提案。
Cancer. 2005 Nov 15;104(10):2116-23. doi: 10.1002/cncr.21465.
9
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.透明细胞肾细胞癌患者根治性肾切除术后进展的预测:一种用于前瞻性临床试验的分层工具。
Cancer. 2003 Apr 1;97(7):1663-71. doi: 10.1002/cncr.11234.
10
Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.预测转移性肾细胞癌患者肾切除术后及免疫治疗后生存率的评分算法:一种用于前瞻性临床试验的分层工具。
Cancer. 2003 Dec 15;98(12):2566-75. doi: 10.1002/cncr.11851.

引用本文的文献

1
Small Renal Cell Carcinoma Presenting With Testicular Metastasis: A Rare Case of pT1a Disease With an Aggressive Clinical Course.以睾丸转移为表现的小肾癌:一例罕见的pT1a期疾病伴侵袭性临床病程。
Cureus. 2025 Jan 11;17(1):e77304. doi: 10.7759/cureus.77304. eCollection 2025 Jan.
2
Prediction of Distant Metastasis of Renal Cell Carcinoma Based on Interpretable Machine Learning: A Multicenter Retrospective Study.基于可解释机器学习的肾细胞癌远处转移预测:一项多中心回顾性研究
J Multidiscip Healthc. 2025 Jan 16;18:195-207. doi: 10.2147/JMDH.S480747. eCollection 2025.
3
Prognostic Molecular Signatures for Metastatic Potential in Clinically Low-Risk Stage I and II Clear Cell Renal Cell Carcinomas.
临床低风险Ⅰ期和Ⅱ期透明细胞肾细胞癌转移潜能的预后分子特征
Front Oncol. 2020 Aug 11;10:1383. doi: 10.3389/fonc.2020.01383. eCollection 2020.
4
Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma.非转移性肾细胞癌根治性肾切除术后无复发生存、无转移生存、癌症特异性生存和总生存的预后危险因素的回顾性多中心长期随访分析
Front Oncol. 2019 Sep 4;9:859. doi: 10.3389/fonc.2019.00859. eCollection 2019.
5
A retrospective comparative study of progression-free survival and overall survival between metachronous and synchronous metastatic renal cell carcinoma in intermediate- or poor-risk patients treated with VEGF-targeted therapy.一项针对接受VEGF靶向治疗的中危或低危患者中异时性和同时性转移性肾细胞癌无进展生存期和总生存期的回顾性比较研究。
Oncotarget. 2017 Sep 6;8(55):93633-93643. doi: 10.18632/oncotarget.20674. eCollection 2017 Nov 7.
6
Inherent characteristics of metachronous metastatic renal cell carcinoma in the era of targeted agents.靶向药物时代异时性转移性肾细胞癌的内在特征
Oncotarget. 2017 Aug 12;8(45):78825-78837. doi: 10.18632/oncotarget.20230. eCollection 2017 Oct 3.